Clinical Trial Update: Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating add-on therapy with allogeneic umbilical cord mesenchymal stem cells for ST-elevation myocardial infarction; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stem Cells (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Ever Supreme Bio Technology Co., Ltd. | Conditions: ST Elevation Myocardial Infarction | Phase 2 | Status: RECRUITING